Cargando…

Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants

The outbreak of SARS-CoV-2 leading to the declaration of the COVID-19 global pandemic has led to the urgent development and deployment of several COVID-19 vaccines. Many of these new vaccines, including those based on mRNA and adenoviruses, are aimed to generate neutralizing antibodies against the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballesteros-Sanabria, Laura, Pelaez-Prestel, Hector F., Ras-Carmona, Alvaro, Reche, Pedro A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138591/ https://www.ncbi.nlm.nih.gov/pubmed/35625733 http://dx.doi.org/10.3390/biomedicines10050996

Ejemplares similares

BCEPS: A Web Server to Predict Linear B Cell Epitopes with Enhanced Immunogenicity and Cross-Reactivity
por: Ras-Carmona, Alvaro, et al.
Publicado: (2021)

Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
por: Bodas-Pinedo, Andrés, et al.
Publicado: (2023)

Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
por: Bodas-Pinedo, Andrés, et al.
Publicado: (2023)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

Prediction of unconventional protein secretion by exosomes
por: Ras-Carmona, Alvaro, et al.
Publicado: (2021)

Immune Tolerance in the Oral Mucosa
por: Pelaez-Prestel, Hector F., et al.
Publicado: (2021)

Human Oral Epithelial Cells Suppress T Cell Function via Prostaglandin E2 Secretion
por: Sanchez-Trincado, Jose L., et al.
Publicado: (2022)

Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases
por: Fiyouzi, Tara, et al.
Publicado: (2023)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

Identification of CD8(+) T cell epitopes through proteasome cleavage site predictions
por: Gomez-Perosanz, Marta, et al.
Publicado: (2020)

Prediction of B cell epitopes in proteins using a novel sequence similarity-based method
por: Ras-Carmona, Alvaro, et al.
Publicado: (2022)

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines
por: Reche, Pedro A.
Publicado: (2020)

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
por: Shi, Juan, et al.
Publicado: (2022)

Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants
por: Montgomerie, Isabelle, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
por: Martínez-Flores, Daniel, et al.
Publicado: (2021)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age
por: Ponce, Pedro, et al.
Publicado: (2022)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
por: Gao, Feixia, et al.
Publicado: (2023)

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
por: Pavot, Vincent, et al.
Publicado: (2022)

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
por: Marzi, Roberta, et al.
Publicado: (2022)

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
por: Marzi, Roberta, et al.
Publicado: (2022)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy
por: Sankaranarayanan, S., et al.
Publicado: (2022)

Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
por: Liu, Xueqiao, et al.
Publicado: (2023)

Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
por: Paul, Debadrita, et al.
Publicado: (2021)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes
por: Odainic, Alexandru, et al.
Publicado: (2022)

Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
por: Hajnik, Renee L., et al.
Publicado: (2022)

Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
por: Pillay, Aleha, et al.
Publicado: (2023)

SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
por: Strong, Thomas A., et al.
Publicado: (2021)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_krl3jdhac5pi214b53dn9akmmp